2015 Q3 Form 10-Q Financial Statement
#000072312515000063 Filed on July 10, 2015
Income Statement
Concept | 2015 Q3 | 2015 Q2 | 2014 Q2 |
---|---|---|---|
Revenue | $3.600B | $3.853B | $3.982B |
YoY Change | -14.83% | -3.24% | 71.79% |
Cost Of Revenue | $2.630B | $2.651B | $2.614B |
YoY Change | -7.46% | 1.42% | 48.35% |
Gross Profit | $970.0M | $1.202B | $1.368B |
YoY Change | -29.96% | -12.13% | 146.04% |
Gross Profit Margin | 26.94% | 31.2% | 34.35% |
Selling, General & Admin | $170.0M | $169.0M | $174.0M |
YoY Change | -5.56% | -2.87% | 37.01% |
% of Gross Profit | 17.53% | 14.06% | 12.72% |
Research & Development | $379.0M | $406.0M | $349.0M |
YoY Change | 5.87% | 16.33% | 54.42% |
% of Gross Profit | 39.07% | 33.78% | 25.51% |
Depreciation & Amortization | $710.0M | $644.0M | $508.0M |
YoY Change | 28.39% | 26.77% | 20.67% |
% of Gross Profit | 73.2% | 53.58% | 37.13% |
Operating Expenses | $543.0M | $575.0M | $523.0M |
YoY Change | 85.96% | 9.94% | 48.16% |
Operating Profit | $427.0M | $631.0M | $839.0M |
YoY Change | -48.43% | -24.79% | 463.09% |
Interest Expense | -$91.00M | $97.00M | $80.00M |
YoY Change | 8.33% | 21.25% | 48.15% |
% of Operating Profit | -21.31% | 15.37% | 9.54% |
Other Income/Expense, Net | $19.00M | -$16.00M | -$21.00M |
YoY Change | -45.71% | -23.81% | -53.33% |
Pretax Income | $355.0M | $527.0M | $743.0M |
YoY Change | -62.43% | -29.07% | 1328.85% |
Income Tax | -$69.00M | $104.0M | $72.00M |
% Of Pretax Income | -19.44% | 19.73% | 9.69% |
Net Earnings | $471.0M | $491.0M | $806.0M |
YoY Change | -59.04% | -39.08% | 1774.42% |
Net Earnings / Revenue | 13.08% | 12.74% | 20.24% |
Basic Earnings Per Share | $0.44 | $0.46 | $0.76 |
Diluted Earnings Per Share | $0.42 | $0.42 | $0.68 |
COMMON SHARES | |||
Basic Shares Outstanding | 1.083B shares | 1.073B shares | 1.067B shares |
Diluted Shares Outstanding | 1.170B shares | 1.190B shares |
Balance Sheet
Concept | 2015 Q3 | 2015 Q2 | 2014 Q2 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $3.521B | $4.860B | $4.264B |
YoY Change | -22.34% | 13.98% | 67.08% |
Cash & Equivalents | $2.287B | $3.694B | $4.062B |
Short-Term Investments | $1.234B | $1.166B | $202.0M |
Other Short-Term Assets | $228.0M | $237.0M | $194.0M |
YoY Change | -34.86% | 22.16% | 95.96% |
Inventory | $2.340B | $2.381B | $2.532B |
Prepaid Expenses | |||
Receivables | $2.188B | $2.261B | $2.357B |
Other Receivables | $319.0M | $269.0M | $358.0M |
Total Short-Term Assets | $8.596B | $10.01B | $9.705B |
YoY Change | -16.1% | 3.12% | 64.88% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $10.55B | $9.857B | $8.021B |
YoY Change | 21.56% | 22.89% | 17.44% |
Goodwill | |||
YoY Change | |||
Intangibles | $449.0M | ||
YoY Change | |||
Long-Term Investments | $1.379B | $1.324B | $744.0M |
YoY Change | 42.02% | 77.96% | 173.53% |
Other Assets | $455.0M | $493.0M | $444.0M |
YoY Change | 9.64% | 11.04% | 14.14% |
Total Long-Term Assets | $15.55B | $15.13B | $10.79B |
YoY Change | 27.74% | 40.2% | 32.08% |
TOTAL ASSETS | |||
Total Short-Term Assets | $8.596B | $10.01B | $9.705B |
Total Long-Term Assets | $15.55B | $15.13B | $10.79B |
Total Assets | $24.14B | $25.14B | $20.50B |
YoY Change | 7.7% | 22.64% | 45.82% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $1.020B | $1.000B | $1.348B |
YoY Change | 2.41% | -25.82% | 83.15% |
Accrued Expenses | $321.0M | $340.0M | $410.0M |
YoY Change | -29.61% | -17.07% | 89.81% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $1.089B | $1.148B | $1.508B |
YoY Change | -33.52% | -23.87% | 322.41% |
Total Short-Term Liabilities | $3.905B | $4.566B | $4.760B |
YoY Change | -18.49% | -4.08% | 103.25% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $6.301B | $6.451B | $4.225B |
YoY Change | 25.72% | 52.69% | 29.32% |
Other Long-Term Liabilities | $698.0M | $764.0M | $813.0M |
YoY Change | -36.66% | -6.03% | 93.57% |
Total Long-Term Liabilities | $698.0M | $764.0M | $813.0M |
YoY Change | -36.66% | -6.03% | -77.95% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $3.905B | $4.566B | $4.760B |
Total Long-Term Liabilities | $698.0M | $764.0M | $813.0M |
Total Liabilities | $10.86B | $11.73B | $9.710B |
YoY Change | 0.64% | 20.83% | 61.05% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | $5.588B | $5.117B | $1.579B |
YoY Change | 104.76% | 224.07% | -182.24% |
Common Stock | $7.582B | $7.536B | $8.317B |
YoY Change | -4.93% | -9.39% | -9.39% |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | $881.0M | $192.0M | |
YoY Change | |||
Treasury Stock Shares | 45.00M shares | ||
Shareholders Equity | $12.30B | $12.46B | $9.940B |
YoY Change | |||
Total Liabilities & Shareholders Equity | $24.14B | $25.14B | $20.50B |
YoY Change | 7.7% | 22.64% | 45.82% |
Cashflow Statement
Concept | 2015 Q3 | 2015 Q2 | 2014 Q2 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $471.0M | $491.0M | $806.0M |
YoY Change | -59.04% | -39.08% | 1774.42% |
Depreciation, Depletion And Amortization | $710.0M | $644.0M | $508.0M |
YoY Change | 28.39% | 26.77% | 20.67% |
Cash From Operating Activities | $1.030B | $1.335B | $1.455B |
YoY Change | -23.53% | -8.25% | 133.17% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$1.765B | -$734.0M | -$566.0M |
YoY Change | 35.04% | 29.68% | 178.82% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $255.0M | -$786.0M | $15.00M |
YoY Change | -165.22% | -5340.0% | -53.13% |
Cash From Investing Activities | -$1.510B | -$1.520B | -$551.0M |
YoY Change | -11.07% | 175.86% | 222.22% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -933.0M | 359.0M | -1.149B |
YoY Change | -305.51% | -131.24% | 1452.7% |
NET CHANGE | |||
Cash From Operating Activities | 1.030B | 1.335B | 1.455B |
Cash From Investing Activities | -1.510B | -1.520B | -551.0M |
Cash From Financing Activities | -933.0M | 359.0M | -1.149B |
Net Change In Cash | -1.413B | 174.0M | -245.0M |
YoY Change | -1471.84% | -171.02% | -164.64% |
FREE CASH FLOW | |||
Cash From Operating Activities | $1.030B | $1.335B | $1.455B |
Capital Expenditures | -$1.765B | -$734.0M | -$566.0M |
Free Cash Flow | $2.795B | $2.069B | $2.021B |
YoY Change | 5.31% | 2.38% | 144.38% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--09-03 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2015 | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2015-06-04 | ||
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000723125 | ||
CY2015Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
1083435628 | shares |
dei |
Entity Filer Category
EntityFilerCategory
|
Large Accelerated Filer | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
MICRON TECHNOLOGY INC | ||
mu |
Accumulated Depreciation Depletion And Amortization Sale Disposal Or Other Adjustment Of Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationSaleDisposalOrOtherAdjustmentOfPropertyPlantAndEquipment
|
461000000 | USD | |
mu |
Accumulated Depreciation Depletionand Amortization Additiondueto Current Period Depreciation Expenseof Property Plantand Equipment
AccumulatedDepreciationDepletionandAmortizationAdditionduetoCurrentPeriodDepreciationExpenseofPropertyPlantandEquipment
|
1868000000 | USD | |
CY2014Q2 | mu |
Business Combination Provisional Information Initial Accounting Incomplete Adjustment To Bargain Purchase Gain Recognized Amount
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentToBargainPurchaseGainRecognizedAmount
|
0 | USD |
mu |
Business Combination Provisional Information Initial Accounting Incomplete Adjustment To Bargain Purchase Gain Recognized Amount
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentToBargainPurchaseGainRecognizedAmount
|
-33000000 | USD | |
CY2015Q2 | mu |
Business Combination Provisional Information Initial Accounting Incomplete Adjustment To Bargain Purchase Gain Recognized Amount
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentToBargainPurchaseGainRecognizedAmount
|
0 | USD |
mu |
Business Combination Provisional Information Initial Accounting Incomplete Adjustment To Bargain Purchase Gain Recognized Amount
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentToBargainPurchaseGainRecognizedAmount
|
0 | USD | |
mu |
Cash Increase Decrease Net Change As A Result Of Debt Restructure Activities
CashIncreaseDecreaseNetChangeAsAResultOfDebtRestructureActivities
|
542000000 | USD | |
CY2014Q3 | mu |
Convertible Debt Equity
ConvertibleDebtEquity
|
57000000 | USD |
CY2015Q2 | mu |
Convertible Debt Equity
ConvertibleDebtEquity
|
48000000 | USD |
mu |
Debt Exchange Convertible Debt Face Amount
DebtExchangeConvertibleDebtFaceAmount
|
756000000 | USD | |
mu |
Debt Exchange Convertible Debt Face Amount
DebtExchangeConvertibleDebtFaceAmount
|
0 | USD | |
mu |
Debt Instrument Increase Decrease Net Equity Component
DebtInstrumentIncreaseDecreaseNetEquityComponent
|
-639000000 | USD | |
mu |
Debt Instrument Increase Decrease Net Principal
DebtInstrumentIncreaseDecreaseNetPrincipal
|
1453000000 | USD | |
mu |
Depreciationand Amortizationof Intangible Assets
DepreciationandAmortizationofIntangibleAssets
|
1550000000 | USD | |
mu |
Depreciationand Amortizationof Intangible Assets
DepreciationandAmortizationofIntangibleAssets
|
1957000000 | USD | |
CY2014Q2 | mu |
Dilutive Securities Effecton Basic Earnings Per Share Equity Method Dilutive Effects
DilutiveSecuritiesEffectonBasicEarningsPerShareEquityMethodDilutiveEffects
|
-1000000 | USD |
mu |
Dilutive Securities Effecton Basic Earnings Per Share Equity Method Dilutive Effects
DilutiveSecuritiesEffectonBasicEarningsPerShareEquityMethodDilutiveEffects
|
-1000000 | USD | |
CY2015Q2 | mu |
Dilutive Securities Effecton Basic Earnings Per Share Equity Method Dilutive Effects
DilutiveSecuritiesEffectonBasicEarningsPerShareEquityMethodDilutiveEffects
|
-1000000 | USD |
mu |
Dilutive Securities Effecton Basic Earnings Per Share Equity Method Dilutive Effects
DilutiveSecuritiesEffectonBasicEarningsPerShareEquityMethodDilutiveEffects
|
-3000000 | USD | |
CY2014Q3 | mu |
Equipment Purchase Payable Current
EquipmentPurchasePayableCurrent
|
289000000 | USD |
CY2015Q2 | mu |
Equipment Purchase Payable Current
EquipmentPurchasePayableCurrent
|
1018000000 | USD |
CY2014Q2 | mu |
Gains Losses On Extinguishment Of Debt And Derivative Gain Loss On Derivative Net
GainsLossesOnExtinguishmentOfDebtAndDerivativeGainLossOnDerivativeNet
|
-16000000 | USD |
mu |
Gains Losses On Extinguishment Of Debt And Derivative Gain Loss On Derivative Net
GainsLossesOnExtinguishmentOfDebtAndDerivativeGainLossOnDerivativeNet
|
-171000000 | USD | |
CY2015Q2 | mu |
Gains Losses On Extinguishment Of Debt And Derivative Gain Loss On Derivative Net
GainsLossesOnExtinguishmentOfDebtAndDerivativeGainLossOnDerivativeNet
|
-18000000 | USD |
mu |
Gains Losses On Extinguishment Of Debt And Derivative Gain Loss On Derivative Net
GainsLossesOnExtinguishmentOfDebtAndDerivativeGainLossOnDerivativeNet
|
-48000000 | USD | |
mu |
Noncash Transaction Value Of Consideration Given To Acquire Minority Interest
NoncashTransactionValueOfConsiderationGivenToAcquireMinorityInterest
|
127000000 | USD | |
mu |
Noncash Transaction Value Of Consideration Given To Acquire Minority Interest
NoncashTransactionValueOfConsiderationGivenToAcquireMinorityInterest
|
0 | USD | |
CY2014Q2 | mu |
Other Other Nonoperating Income Expense
OtherOtherNonoperatingIncomeExpense
|
0 | USD |
mu |
Other Other Nonoperating Income Expense
OtherOtherNonoperatingIncomeExpense
|
6000000 | USD | |
CY2015Q2 | mu |
Other Other Nonoperating Income Expense
OtherOtherNonoperatingIncomeExpense
|
1000000 | USD |
mu |
Other Other Nonoperating Income Expense
OtherOtherNonoperatingIncomeExpense
|
3000000 | USD | |
CY2014Q2 | mu |
Other Other Operating Income Expense Net
OtherOtherOperatingIncomeExpenseNet
|
-4000000 | USD |
mu |
Other Other Operating Income Expense Net
OtherOtherOperatingIncomeExpenseNet
|
-9000000 | USD | |
CY2015Q2 | mu |
Other Other Operating Income Expense Net
OtherOtherOperatingIncomeExpenseNet
|
0 | USD |
mu |
Other Other Operating Income Expense Net
OtherOtherOperatingIncomeExpenseNet
|
22000000 | USD | |
mu |
Payments For Derivative And Hedge Investing Activities
PaymentsForDerivativeAndHedgeInvestingActivities
|
25000000 | USD | |
mu |
Payments For Derivative And Hedge Investing Activities
PaymentsForDerivativeAndHedgeInvestingActivities
|
94000000 | USD | |
mu |
Property Plantand Equipment Net Affect Retirementsand Other Adjustments
PropertyPlantandEquipmentNetAffectRetirementsandOtherAdjustments
|
10000000 | USD | |
mu |
Property Plantand Equipment Net Affectof Additionsand Depreciation Expense
PropertyPlantandEquipmentNetAffectofAdditionsandDepreciationExpense
|
1185000000 | USD | |
mu |
Property Plantand Equipment Retirementsand Other
PropertyPlantandEquipmentRetirementsandOther
|
471000000 | USD | |
CY2014Q3 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
2864000000 | USD |
CY2015Q2 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
3204000000 | USD |
CY2014Q3 | us-gaap |
Accounts Payable Other Current
AccountsPayableOtherCurrent
|
281000000 | USD |
CY2015Q2 | us-gaap |
Accounts Payable Other Current
AccountsPayableOtherCurrent
|
298000000 | USD |
CY2014Q3 | us-gaap |
Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
|
673000000 | USD |
CY2015Q2 | us-gaap |
Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
|
387000000 | USD |
CY2014Q3 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
996000000 | USD |
CY2015Q2 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
1000000000 | USD |
CY2014Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
2524000000 | USD |
CY2015Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
2261000000 | USD |
CY2014Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
14750000000 | USD |
CY2015Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
16157000000 | USD |
CY2014Q3 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
56000000 | USD |
CY2015Q2 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-3000000 | USD |
CY2014Q3 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
7879000000 | USD |
CY2015Q2 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
7428000000 | USD |
us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
130000000 | USD | |
us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
105000000 | USD | |
CY2014Q2 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
34000000 | USD |
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
88000000 | USD | |
CY2015Q2 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
29000000 | USD |
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
89000000 | USD | |
CY2014Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
45000000 | shares |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
43000000 | shares | |
CY2015Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
55000000 | shares |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
27000000 | shares | |
CY2014Q3 | us-gaap |
Assets
Assets
|
22498000000 | USD |
CY2015Q2 | us-gaap |
Assets
Assets
|
25136000000 | USD |
CY2014Q3 | us-gaap |
Assets Current
AssetsCurrent
|
10245000000 | USD |
CY2015Q2 | us-gaap |
Assets Current
AssetsCurrent
|
10008000000 | USD |
CY2014Q3 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
5353000000 | USD |
CY2015Q2 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
7330000000 | USD |
CY2015Q2 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
|
0 | USD |
CY2014Q3 | us-gaap |
Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
|
384000000 | USD |
CY2015Q2 | us-gaap |
Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
|
1166000000 | USD |
CY2014Q3 | us-gaap |
Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
|
819000000 | USD |
CY2015Q2 | us-gaap |
Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
|
2470000000 | USD |
CY2013Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2880000000 | USD |
CY2014Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
4062000000 | USD |
CY2014Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
4150000000 | USD |
CY2015Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
3694000000 | USD |
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
1182000000 | USD | |
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-456000000 | USD | |
CY2014Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2015Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2014Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.10 | |
CY2015Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.10 | |
CY2014Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
3000000000 | shares |
CY2015Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
3000000000 | shares |
CY2014Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
1073000000 | shares |
CY2015Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
1083000000 | shares |
CY2014Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
1073000000 | shares |
CY2015Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
1083000000 | shares |
CY2014Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
107000000 | USD |
CY2015Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
108000000 | USD |
CY2014Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
791000000 | USD |
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
1876000000 | USD | |
CY2015Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
506000000 | USD |
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
2369000000 | USD | |
CY2014Q2 | us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
0 | USD |
us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
33000000 | USD | |
CY2015Q2 | us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
0 | USD |
us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
-1000000 | USD | |
CY2014Q2 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
791000000 | USD |
us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
1909000000 | USD | |
CY2015Q2 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
506000000 | USD |
us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
2368000000 | USD | |
CY2014Q2 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
2614000000 | USD |
us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
8079000000 | USD | |
CY2015Q2 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
2651000000 | USD |
us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
8347000000 | USD | |
CY2014Q3 | us-gaap |
Customer Advances Current
CustomerAdvancesCurrent
|
98000000 | USD |
CY2015Q2 | us-gaap |
Customer Advances Current
CustomerAdvancesCurrent
|
79000000 | USD |
CY2014Q3 | us-gaap |
Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
|
6593000000 | USD |
CY2015Q2 | us-gaap |
Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
|
7551000000 | USD |
CY2014Q3 | us-gaap |
Debt Current
DebtCurrent
|
1638000000 | USD |
CY2015Q2 | us-gaap |
Debt Current
DebtCurrent
|
1148000000 | USD |
us-gaap |
Debt Instrument Increase Decrease For Period Net
DebtInstrumentIncreaseDecreaseForPeriodNet
|
1248000000 | USD | |
CY2014Q3 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
309000000 | USD |
CY2015Q2 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
214000000 | USD |
CY2014Q3 | us-gaap |
Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
|
816000000 | USD |
CY2015Q2 | us-gaap |
Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
|
553000000 | USD |
CY2014Q2 | us-gaap |
Depreciation
Depreciation
|
508000000 | USD |
us-gaap |
Depreciation
Depreciation
|
1460000000 | USD | |
CY2015Q2 | us-gaap |
Depreciation
Depreciation
|
644000000 | USD |
us-gaap |
Depreciation
Depreciation
|
1870000000 | USD | |
CY2014Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.76 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.79 | ||
CY2015Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.46 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
2.26 | ||
CY2014Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.68 | |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.58 | ||
CY2015Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.42 | |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
2.05 | ||
us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
|
-13000000 | USD | |
us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
|
-127000000 | USD | |
CY2014Q3 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
456000000 | USD |
CY2015Q2 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
340000000 | USD |
CY2015Q2 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
432000000 | USD |
us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P1Y5M | ||
CY2014Q3 | us-gaap |
Equity Method Investments
EquityMethodInvestments
|
971000000 | USD |
CY2015Q2 | us-gaap |
Equity Method Investments
EquityMethodInvestments
|
1324000000 | USD |
CY2014Q3 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
342000000 | USD |
CY2015Q2 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
405000000 | USD |
CY2015Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
117000000 | USD |
CY2015Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
35000000 | USD |
us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
400000000 | USD | |
CY2015Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
83000000 | USD |
CY2015Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
95000000 | USD |
CY2015Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
107000000 | USD |
CY2014Q3 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
810000000 | USD |
CY2015Q2 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
836000000 | USD |
CY2014Q3 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
468000000 | USD |
CY2015Q2 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
431000000 | USD |
CY2015Q2 | us-gaap |
Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months
ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months
|
4000000 | USD |
CY2014Q2 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-5000000 | USD |
us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-25000000 | USD | |
CY2015Q2 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
1000000 | USD |
us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-26000000 | USD | |
CY2014Q2 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
-2000000 | USD |
us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
-11000000 | USD | |
CY2015Q2 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
4000000 | USD |
us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
14000000 | USD | |
CY2014Q2 | us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
0 | USD |
us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
-233000000 | USD | |
CY2015Q2 | us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
0 | USD |
us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
0 | USD | |
us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-182000000 | USD | |
us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-48000000 | USD | |
CY2014Q2 | us-gaap |
Gross Profit
GrossProfit
|
1368000000 | USD |
us-gaap |
Gross Profit
GrossProfit
|
4052000000 | USD | |
CY2015Q2 | us-gaap |
Gross Profit
GrossProfit
|
1202000000 | USD |
us-gaap |
Gross Profit
GrossProfit
|
4245000000 | USD | |
CY2014Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
743000000 | USD |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
1788000000 | USD | |
CY2015Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
527000000 | USD |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
2254000000 | USD | |
CY2014Q2 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
135000000 | USD |
us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
355000000 | USD | |
CY2014Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
72000000 | USD |
CY2015Q2 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
68000000 | USD |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
215000000 | USD | |
CY2015Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
104000000 | USD |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
226000000 | USD | |
CY2014Q2 | us-gaap |
Income Tax Holiday Aggregate Dollar Amount
IncomeTaxHolidayAggregateDollarAmount
|
88000000 | USD |
us-gaap |
Income Tax Holiday Aggregate Dollar Amount
IncomeTaxHolidayAggregateDollarAmount
|
232000000 | USD | |
CY2015Q2 | us-gaap |
Income Tax Holiday Aggregate Dollar Amount
IncomeTaxHolidayAggregateDollarAmount
|
52000000 | USD |
us-gaap |
Income Tax Holiday Aggregate Dollar Amount
IncomeTaxHolidayAggregateDollarAmount
|
289000000 | USD | |
CY2014Q2 | us-gaap |
Income Tax Holiday Income Tax Benefits Per Share
IncomeTaxHolidayIncomeTaxBenefitsPerShare
|
0.07 | |
us-gaap |
Income Tax Holiday Income Tax Benefits Per Share
IncomeTaxHolidayIncomeTaxBenefitsPerShare
|
0.19 | ||
CY2015Q2 | us-gaap |
Income Tax Holiday Income Tax Benefits Per Share
IncomeTaxHolidayIncomeTaxBenefitsPerShare
|
0.04 | |
us-gaap |
Income Tax Holiday Income Tax Benefits Per Share
IncomeTaxHolidayIncomeTaxBenefitsPerShare
|
0.24 | ||
CY2014Q3 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
104000000 | USD |
CY2015Q2 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
81000000 | USD |
us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
-184000000 | USD | |
us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
-248000000 | USD | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-117000000 | USD | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-75000000 | USD | |
us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
646000000 | USD | |
us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
-533000000 | USD | |
us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
185000000 | USD | |
us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
-8000000 | USD | |
us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
330000000 | USD | |
us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
-337000000 | USD | |
us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
-559000000 | USD | |
us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
0 | USD | |
CY2014Q2 | us-gaap |
Interest Expense
InterestExpense
|
80000000 | USD |
us-gaap |
Interest Expense
InterestExpense
|
264000000 | USD | |
CY2015Q2 | us-gaap |
Interest Expense
InterestExpense
|
97000000 | USD |
us-gaap |
Interest Expense
InterestExpense
|
270000000 | USD | |
CY2014Q3 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
898000000 | USD |
CY2015Q2 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
774000000 | USD |
CY2014Q3 | us-gaap |
Inventory Net
InventoryNet
|
2455000000 | USD |
CY2015Q2 | us-gaap |
Inventory Net
InventoryNet
|
2381000000 | USD |
CY2014Q3 | us-gaap |
Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
|
185000000 | USD |
CY2015Q2 | us-gaap |
Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
|
243000000 | USD |
CY2014Q3 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
1372000000 | USD |
CY2015Q2 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
1364000000 | USD |
CY2014Q2 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
5000000 | USD |
us-gaap |
Investment Income Net
InvestmentIncomeNet
|
16000000 | USD | |
CY2015Q2 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
9000000 | USD |
us-gaap |
Investment Income Net
InvestmentIncomeNet
|
24000000 | USD | |
CY2014Q3 | us-gaap |
Liabilities
Liabilities
|
10868000000 | USD |
CY2015Q2 | us-gaap |
Liabilities
Liabilities
|
11733000000 | USD |
CY2014Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
22498000000 | USD |
CY2015Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
25136000000 | USD |
CY2014Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4811000000 | USD |
CY2015Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4566000000 | USD |
CY2014Q3 | us-gaap |
Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
|
4955000000 | USD |
CY2015Q2 | us-gaap |
Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
|
6403000000 | USD |
CY2014Q3 | us-gaap |
Minority Interest
MinorityInterest
|
802000000 | USD |
CY2015Q2 | us-gaap |
Minority Interest
MinorityInterest
|
897000000 | USD |
us-gaap |
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
|
19000000 | USD | |
us-gaap |
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
|
6000000 | USD | |
us-gaap |
Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
|
146000000 | USD | |
us-gaap |
Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
|
0 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
-1953000000 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
215000000 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-1204000000 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-4722000000 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
4352000000 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
4178000000 | USD | |
CY2014Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
806000000 | USD |
us-gaap |
Net Income Loss
NetIncomeLoss
|
1895000000 | USD | |
CY2015Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
491000000 | USD |
us-gaap |
Net Income Loss
NetIncomeLoss
|
2428000000 | USD | |
CY2014Q2 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
0 | USD |
us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
33000000 | USD | |
CY2015Q2 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
0 | USD |
us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
0 | USD | |
CY2014Q2 | us-gaap |
Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
|
805000000 | USD |
us-gaap |
Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
|
1894000000 | USD | |
CY2015Q2 | us-gaap |
Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
|
490000000 | USD |
us-gaap |
Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
|
2425000000 | USD | |
us-gaap |
Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
|
59000000 | USD | |
us-gaap |
Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
|
102000000 | USD | |
CY2014Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
839000000 | USD |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
2259000000 | USD | |
CY2015Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
631000000 | USD |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
2571000000 | USD | |
CY2014Q3 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
350000000 | USD |
CY2015Q2 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
237000000 | USD |
CY2014Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
497000000 | USD |
CY2015Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
493000000 | USD |
CY2014Q2 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
0 | USD |
us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
2000000 | USD | |
CY2015Q2 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
-2000000 | USD |
us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
-3000000 | USD | |
CY2014Q2 | us-gaap |
Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
|
-2000000 | USD |
us-gaap |
Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
|
-6000000 | USD | |
CY2015Q2 | us-gaap |
Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
|
-1000000 | USD |
us-gaap |
Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
|
-19000000 | USD | |
CY2014Q2 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-13000000 | USD |
us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-17000000 | USD | |
CY2015Q2 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
17000000 | USD |
us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-57000000 | USD | |
CY2014Q2 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-15000000 | USD |
us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-19000000 | USD | |
CY2015Q2 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
15000000 | USD |
us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-60000000 | USD | |
CY2014Q2 | us-gaap |
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
0 | USD |
us-gaap |
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
-2000000 | USD | |
CY2015Q2 | us-gaap |
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
-1000000 | USD |
us-gaap |
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
-19000000 | USD | |
CY2014Q3 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
1102000000 | USD |
CY2015Q2 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
764000000 | USD |
CY2014Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-21000000 | USD |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-223000000 | USD | |
CY2015Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-16000000 | USD |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-71000000 | USD | |
us-gaap |
Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
|
34000000 | USD | |
us-gaap |
Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
|
-206000000 | USD | |
CY2014Q2 | us-gaap |
Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
|
-6000000 | USD |
us-gaap |
Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
|
-253000000 | USD | |
CY2015Q2 | us-gaap |
Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
|
4000000 | USD |
us-gaap |
Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
|
36000000 | USD | |
CY2014Q3 | us-gaap |
Other Receivables
OtherReceivables
|
278000000 | USD |
CY2015Q2 | us-gaap |
Other Receivables
OtherReceivables
|
188000000 | USD |
us-gaap |
Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
|
-95000000 | USD | |
us-gaap |
Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
|
-51000000 | USD | |
us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
75000000 | USD | |
us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
245000000 | USD | |
us-gaap |
Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
|
475000000 | USD | |
us-gaap |
Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
|
3809000000 | USD | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1800000000 | USD | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
2256000000 | USD | |
us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
1062000000 | USD | |
us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
2172000000 | USD | |
us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
247000000 | USD | |
us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
64000000 | USD | |
us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
-67000000 | USD | |
us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
-16000000 | USD | |
us-gaap |
Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
|
442000000 | USD | |
us-gaap |
Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
|
1386000000 | USD | |
CY2014Q2 | us-gaap |
Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
|
78000000 | USD |
us-gaap |
Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
|
301000000 | USD | |
CY2015Q2 | us-gaap |
Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
|
562000000 | USD |
us-gaap |
Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
|
938000000 | USD | |
CY2014Q2 | us-gaap |
Profit Loss
ProfitLoss
|
806000000 | USD |
us-gaap |
Profit Loss
ProfitLoss
|
1928000000 | USD | |
CY2015Q2 | us-gaap |
Profit Loss
ProfitLoss
|
491000000 | USD |
us-gaap |
Profit Loss
ProfitLoss
|
2428000000 | USD | |
us-gaap |
Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
|
3053000000 | USD | |
CY2014Q3 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
23432000000 | USD |
CY2015Q2 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
26014000000 | USD |
CY2014Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
8682000000 | USD |
CY2015Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
9857000000 | USD |
CY2014Q3 | us-gaap |
Receivables Net Current
ReceivablesNetCurrent
|
2906000000 | USD |
CY2015Q2 | us-gaap |
Receivables Net Current
ReceivablesNetCurrent
|
2530000000 | USD |
us-gaap |
Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
|
3134000000 | USD | |
us-gaap |
Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
|
2051000000 | USD | |
CY2014Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
349000000 | USD |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1013000000 | USD | |
CY2015Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
406000000 | USD |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1161000000 | USD | |
CY2014Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
2729000000 | USD |
CY2015Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
5117000000 | USD |
us-gaap |
Sale Leaseback Transaction Gross Proceeds Financing Activities
SaleLeasebackTransactionGrossProceedsFinancingActivities
|
14000000 | USD | |
us-gaap |
Sale Leaseback Transaction Gross Proceeds Financing Activities
SaleLeasebackTransactionGrossProceedsFinancingActivities
|
291000000 | USD | |
CY2014Q2 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
3982000000 | USD |
us-gaap |
Sales Revenue Net
SalesRevenueNet
|
12131000000 | USD | |
CY2015Q2 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
3853000000 | USD |
us-gaap |
Sales Revenue Net
SalesRevenueNet
|
12592000000 | USD | |
CY2014Q2 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
174000000 | USD |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
527000000 | USD | |
CY2015Q2 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
169000000 | USD |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
549000000 | USD | |
CY2014Q2 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
32000000 | USD |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
81000000 | USD | |
CY2015Q2 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
43000000 | USD |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
127000000 | USD | |
CY2015Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
171000000 | shares |
CY2015Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
|
111000000 | shares |
CY2015Q2 | us-gaap |
Share Price
SharePrice
|
26.99 | |
CY2015Q2 | us-gaap |
Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Estimated Range Of Change Lower Bound
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleEstimatedRangeOfChangeLowerBound
|
0 | USD |
CY2015Q2 | us-gaap |
Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Estimated Range Of Change Upper Bound
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleEstimatedRangeOfChangeUpperBound
|
70000000 | USD |
CY2015Q2 | us-gaap |
Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
|
1000000000 | USD |
CY2015Q2 | us-gaap |
Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
|
808000000 | USD |
us-gaap |
Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
|
7000000 | shares | |
us-gaap |
Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
|
2000000 | shares | |
us-gaap |
Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
|
75000000 | USD | |
us-gaap |
Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
|
53000000 | USD | |
CY2014Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
10771000000 | USD |
CY2015Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
12458000000 | USD |
CY2013Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
10006000000 | USD |
CY2014Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
10697000000 | USD |
CY2014Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
11573000000 | USD |
CY2015Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
13355000000 | USD |
us-gaap |
Stockholders Equity Other
StockholdersEquityOther
|
1112000000 | USD | |
us-gaap |
Stockholders Equity Other
StockholdersEquityOther
|
682000000 | USD | |
CY2014Q3 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
71000000 | USD |
CY2015Q2 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
82000000 | USD |
CY2015Q1 | us-gaap |
Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
|
7000000 | shares |
CY2014Q3 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
0 | USD |
CY2015Q2 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
192000000 | USD |
CY2015Q1 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
192000000 | USD |
CY2014Q2 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
123000000 | shares |
us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
138000000 | shares | |
CY2015Q2 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
97000000 | shares |
us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
113000000 | shares | |
CY2014Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
1190000000 | shares |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
1196000000 | shares | |
CY2015Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
1170000000 | shares |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
1185000000 | shares | |
CY2014Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
1067000000 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
1058000000 | shares | |
CY2015Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
1073000000 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
1072000000 | shares | |
us-gaap |
Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Recently Issued Accounting Standards</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2015, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2015-05 </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">– Customer's Accounting for Fees Paid in a Cloud Computing Arrangement</font><font style="font-family:inherit;font-size:10pt;">, which provides additional guidance to customers about whether a cloud computing arrangement includes a software license. Under ASU 2015-05, if a software cloud computing arrangement contains a software license, customers should account for the license element of the arrangement in a manner consistent with the acquisition of other software licenses. If the arrangement does not contain a software license, customers should account for the arrangement as a service contract. ASU 2015-05 also removes the requirement to analogize to ASC 840-10 </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">–</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:10pt;"> to determine the asset acquired in a software licensing arrangement. This ASU will be effective for us beginning in our first quarter of 2017 and early adoption is permitted.  We are evaluating the effects of the adoption of this ASU on our financial statements.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2015, the FASB issued ASU 2015-03 </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">– Simplifying the Presentation of Debt Issuance Costs</font><font style="font-family:inherit;font-size:10pt;">, which requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. This ASU requires retrospective adoption and will be effective for us beginning in our first quarter of 2017. Early adoption is permitted. We do not expect this adoption to have a material impact on our financial statements.</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2015, the FASB issued ASU 2015-02 – </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Amendments to the Consolidation Analysis</font><font style="font-family:inherit;font-size:10pt;">, which amends the consolidation requirements in Accounting Standards Codification 810 </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">–</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Consolidation</font><font style="font-family:inherit;font-size:10pt;">.  ASU 2015-02 makes targeted amendments to the current consolidation guidance for VIEs, which could change consolidation conclusions.  This ASU will be effective for us beginning in our first quarter of 2017 and early adoption is permitted.  We are evaluating the effects of the adoption of this ASU on our financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued ASU 2014-09 – </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:10pt;">, which will supersede nearly all existing revenue recognition guidance under generally accepted accounting principles in the U.S.  The core principal of this ASU is that an entity should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.  This ASU also requires additional disclosure about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract.  This ASU will be effective for us in our first quarter of 2018.  Early adoption is not permitted. This ASU allows for either full retrospective or modified retrospective adoption. We are evaluating the transition method we will elect and the effects of the adoption of this ASU on our financial statements.</font></div></div> | ||
us-gaap |
Fiscal Period
FiscalPeriod
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Fiscal year 2015 contains 53 weeks and the third quarter and first nine months of 2015, which ended on </font><font style="font-family:inherit;font-size:10pt;">June 4, 2015</font><font style="font-family:inherit;font-size:10pt;">, contained 13 weeks and 40 weeks, respectively. Fiscal year 2014 contained 52 weeks and the third quarter and first nine months of 2014, which ended on </font><font style="font-family:inherit;font-size:10pt;">May 29, 2014</font><font style="font-family:inherit;font-size:10pt;">, contained 13 weeks and 39 weeks, respectively. All period references are to our fiscal periods unless otherwise indicated. These interim financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended August 28, 2014.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> | ||
us-gaap |
Loss Contingency Disclosures
LossContingencyDisclosures
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Contingencies</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have accrued a liability and charged operations for the estimated costs of adjudication or settlement of various asserted and unasserted claims existing as of the applicable balance sheet dates, including those described below. We are currently a party to other legal actions arising from the normal course of business, none of which is expected to have a material adverse effect on our business, results of operations, or financial condition.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Patent Matters</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As is typical in the semiconductor and other high technology industries, from time to time others have asserted, and may in the future assert, that our products or manufacturing processes infringe their intellectual property rights.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On September 1, 2011, HSM Portfolio LLC and Technology Properties Limited LLC filed a patent infringement action in the U.S. District Court for the District of Delaware against us and seventeen other defendants, including MMJ and Elpida Memory (USA) Inc.  On August 22, 2013, the plaintiffs filed a third amended complaint. The third amended complaint alleges that certain of our DRAM and image sensor products infringe four U.S. patents and that certain MMJ and Elpida Memory (USA) Inc. DRAM products infringe two U.S. patents and seeks damages, attorneys' fees, and costs. Trial currently is scheduled for February 22, 2016. On March 23, 2012, MMJ and Elpida Memory (USA) Inc. filed a Notice of Filing and Hearing on Petition Under Chapter 15 of the U.S. Bankruptcy Code and Issuance of Provisional Relief that included an order of the U.S. Bankruptcy Court for the District of Delaware staying judicial proceedings against MMJ and Elpida Memory (USA) Inc. Accordingly, the plaintiffs' case against MMJ and Elpida Memory (USA) was stayed.  On June 25, 2013, the U.S. Bankruptcy Court for the District of Delaware entered its Order (1) granting recognition of the Japanese reorganization plan of MMJ and the Japan Court's confirmation orders, (2) entrusting MMJ's U.S. assets to foreign representatives and approving certain plan transactions, (3) granting permanent injunction, and (4) granting related relief (the "Recognition Order").  Pursuant to the Recognition Order, the plaintiffs are permanently enjoined from continuing their case against MMJ and Elpida Memory (USA) Inc. in respect of any claim or claims arising prior to the commencement of the Japan Proceeding (as defined in the Recognition Order).</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 5, 2011, the Board of Trustees for the University of Illinois (the "University") filed a patent infringement action against us in the U.S. District Court for the Central District of Illinois. The complaint alleges that unspecified semiconductor products of ours infringe three U.S. patents and seeks injunctive relief, damages, attorneys' fees, and costs. We have filed three petitions for inter-partes review by the Patent and Trademark Office, challenging the validity of each of the patents in suit. The Patent Trial and Appeal Board ("PTAB") held a hearing on December 9, 2013 in connection with the three petitions. On March 10, 2014, the PTAB issued written decisions finding that each and every claim in the three patents in suit is invalid, and cancelled all claims. The University appealed the PTAB rulings to the U.S. Court of Appeals for the Federal Circuit, and a hearing was held on March 4, 2015. On March 12, 2015, the appeals court issued orders that summarily affirm the PTAB ruling that all claims of each patent are invalid.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 27, 2012, Semcon Tech, LLC filed a patent infringement action against us in the U.S. District Court for the District of Delaware. The complaint alleges that our use of various chemical mechanical planarization systems purchased from Applied Materials, Inc. infringes a single U.S. patent and seeks injunctive relief, damages, attorneys' fees, and costs. Trial currently is scheduled for August 31, 2015.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On November 21, 2014, Elm 3DS Innovations, LLC ("Elm") filed a patent infringement action against MTI, Micron Semiconductor Products, Inc., and Micron Consumer Products Group, Inc. in the U.S. District Court for the District of Delaware. On March 27, 2015, Elm filed an amended complaint against the same entities. The amended complaint alleges that unspecified semiconductor products of ours that incorporate multiple stacked die infringe thirteen U.S. patents and seeks damages, attorneys’ fees, and costs.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 15, 2014, Innovative Memory Solutions, Inc. filed a patent infringement action against us in the U.S. District Court for the District of Delaware.  The complaint alleges that a variety of our NAND Flash products infringe eight U.S. patents and seeks damages, attorneys' fees, and costs.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Among other things, the above lawsuits pertain to certain of our DDR DRAM, DDR2 DRAM, DDR3 DRAM, DDR4 DRAM, SDR SDRAM, PSRAM, RLDRAM, LPDRAM, NAND Flash, image sensor products, and certain other memory products we manufacture, which account for a significant portion of our net sales.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are unable to predict the outcome of assertions of infringement made against us and therefore cannot estimate the range of possible loss. A determination that our products or manufacturing processes infringe the intellectual property rights of others or entering into a license agreement covering such intellectual property could result in significant liability and/or require us to make material changes to our products and/or manufacturing processes. Any of the foregoing could have a material adverse effect on our business, results of operations, or financial condition.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Antitrust Matters</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At least sixty-eight purported class action price-fixing lawsuits have been filed against us and other DRAM suppliers in various federal and state courts in the United States and in Puerto Rico on behalf of indirect purchasers alleging a conspiracy to increase DRAM prices in violation of federal and state antitrust laws and state unfair competition law, and/or unjust enrichment relating to the sale and pricing of DRAM products during the period from April 1999 through at least June 2002. The complaints seek joint and several damages, trebled, in addition to restitution, costs, and attorneys' fees. A number of these cases were removed to federal court and transferred to the U.S. District Court for the Northern District of California for consolidated pre-trial proceedings. In July 2006, the Attorneys General for approximately forty U.S. states and territories filed suit in the U.S. District Court for the Northern District of California. The complaints allege, among other things, violations of the Sherman Act, Cartwright Act, and certain other states' consumer protection and antitrust laws and seek joint and several damages, trebled, as well as injunctive and other relief. On October 3, 2008, the California Attorney General filed a similar lawsuit in California Superior Court, purportedly on behalf of local California government entities, alleging, among other things, violations of the Cartwright Act and state unfair competition law. On June 23, 2010, we executed a settlement agreement resolving these purported class-action indirect purchaser cases and the pending cases of the Attorneys General relating to alleged DRAM price-fixing in the United States. Subject to certain conditions, including final court approval of the class settlements, we agreed to pay approximately $67 million in aggregate in three equal installments over a two-year period. We paid the full amount into an escrow account by the end of the first quarter of 2013 in accordance with the settlement agreement.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 21, 2010, the Brazil Secretariat of Economic Law of the Ministry of Justice ("SDE") announced that it had initiated an investigation relating to alleged anticompetitive activities within the DRAM industry. The SDE's Notice of Investigation names various DRAM manufacturers and certain executives, including us, and focuses on the period from July 1998 to June 2002.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are unable to predict the outcome of these matters and therefore cannot estimate the range of possible loss, except as noted in the above discussion of the U.S. indirect purchaser cases. The final resolution of these alleged violations of antitrust laws could result in significant liability and could have a material adverse effect on our business, results of operations, or financial condition.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Securities Matters</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 12, 2013, seven former shareholders of Elpida (now known as MMJ) filed a complaint against Messrs. Sakamoto, Adachi, Gomi, Shirai, Tsay-Jiu, Wataki, Kinoshita, and Takahasi in their capacity as members of the board of directors of MMJ as of February 2012. The complaint alleges that the defendants engaged in various acts and misrepresentations to hide the financial condition of MMJ and deceive shareholders prior to MMJ filing a petition for corporate reorganization on February 27, 2012. The plaintiffs seek joint and several damages equal to the market value of shares owned by each of the plaintiffs on February 23, 2012, along with attorneys' fees and interest. At a hearing on September 25, 2013, the plaintiffs withdrew the complaint against Mr. Tsay-Jiu.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are unable to predict the outcome of this matter and therefore cannot estimate the range of possible loss.  The final resolution of this matter could result in significant liability and could have a material adverse effect on our business, results of operations, or financial condition.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Qimonda</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 20, 2011, Dr. Michael Jaffé, administrator for Qimonda insolvency proceedings, filed suit against MTI and Micron Semiconductor B.V., our Netherlands subsidiary ("Micron B.V."), in the District Court of Munich, Civil Chamber. The complaint seeks to void under Section 133 of the German Insolvency Act a share purchase agreement between Micron B.V. and Qimonda signed in fall 2008 pursuant to which Micron B.V. purchased substantially all of Qimonda's shares of Inotera Memories, Inc. (the "Inotera Shares"), representing approximately 55% of our total shares in Inotera as of June 4, 2015, and seeks an order requiring us to re-transfer those shares to the Qimonda estate. The complaint also seeks, among other things, to recover damages for the alleged value of the joint venture relationship with Inotera and to terminate under Sections 103 or 133 of the German Insolvency Code a patent cross-license between us and Qimonda entered into at the same time as the share purchase agreement.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Following a series of hearings with pleadings, arguments and witnesses on behalf of the Qimonda estate, on March 13, 2014, the Court issued judgments:  (1) ordering Micron B.V. to pay approximately $1 million in respect of certain Inotera shares sold in connection with the original share purchase; (2) ordering Micron B.V. to disclose certain information with respect to any Inotera Shares sold by it to third parties; (3) ordering Micron B.V. to disclose the benefits derived by it from ownership of the Inotera Shares, including in particular, any profits distributed on such shares and all other benefits; (4) denying Qimonda’s claims against MTI for any damages relating to the joint venture relationship with Inotera; and (5) determining that Qimonda's obligations under the patent cross-license agreement are cancelled. In addition, the Court issued interlocutory judgments ordering, among other things:  (1) that Micron B.V. transfer to the Qimonda estate the Inotera Shares still owned by it and pay to the Qimonda estate compensation in an amount to be specified for any Inotera Shares sold to third parties; and (2) that Micron B.V. pay the Qimonda estate as compensation an amount to be specified for benefits derived by it from ownership of the Inotera Shares. The interlocutory judgments have no immediate, enforceable effect on us, and, accordingly, we expect to be able to continue to operate with full control of the Inotera Shares subject to further developments in the case. We have filed a notice of appeal, and the parties have submitted briefs to the appeals court. A hearing on the matter was held on July 9, 2015 during which an additional hearing was scheduled for September 29, 2015.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are unable to predict the outcome of the matter and therefore cannot estimate the range of possible loss. The final resolution of this lawsuit could result in the loss of the Inotera Shares or monetary damages, unspecified damages based on the benefits derived by Micron B.V. from the ownership of the Inotera Shares, and/or the termination of the patent cross-license, which could have a material adverse effect on our business, results of operation, or financial condition.  As of June 4, 2015, the Inotera Shares had a carrying value in equity method investments for purposes of our financial reporting of $703 million and a market value of $1.25 billion.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Other</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the normal course of business, we are a party to a variety of agreements pursuant to which we may be obligated to indemnify the other party. It is not possible to predict the maximum potential amount of future payments under these types of agreements due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement. Historically, our payments under these types of agreements have not had a material adverse effect on our business, results of operations, or financial condition.</font></div></div> | ||
us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications have been made to prior period amounts to conform to current period presentation. In addition, amounts for certain equipment purchases were reclassified from financing to investing within the statement of cash flows to better reflect the current nature of these transactions and to improve comparability with our industry peers.</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> |